Loading...
•
Jun 30, 2023
Astrana Health Q2 2023 Earnings Report
ApolloMed's second quarter performance reflected sustained momentum and scalability, with revenue up 29%, net income attributable to ApolloMed up 10%, and adjusted EBITDA up 44% compared to a year ago.
Key Takeaways
Apollo Medical Holdings, Inc. reported strong second quarter results with a 29% increase in revenue and a 10% increase in net income attributable to ApolloMed. The company reiterated its full-year 2023 guidance.
Revenue increased by 29% compared to the previous year.
Net income attributable to ApolloMed increased by 10% compared to the previous year.
Adjusted EBITDA increased by 44% compared to the previous year.
The company reiterated its previously provided guidance for full-year 2023.
Forward Guidance
ApolloMed reiterated its full-year 2023 guidance for total revenue, net income, EBITDA, Adjusted EBITDA, and EPS - diluted, based on the Company’s existing business, current view of existing market conditions and assumptions.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...